Total Payments
$6,387
2024 Payments
$238.09
Companies
9
Transactions
38
Medicare Patients
1,859
Medicare Billing
$269,381
Payment Breakdown by Category
Education$3,333 (52.2%)
Food & Beverage$1,570 (24.6%)
Travel$1,483 (23.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $3,333 | 1 | 52.2% |
| Food and Beverage | $1,570 | 34 | 24.6% |
| Travel and Lodging | $1,483 | 3 | 23.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $4,674 | 5 | $0 (2020) |
| The Spectranetics Corporation | $1,016 | 9 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $180.74 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $142.44 | 7 | $0 (2022) |
| ARALEZ PHARMACEUTICALS US INC. | $136.25 | 2 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $115.75 | 5 | $0 (2024) |
| Amgen Inc. | $54.73 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $53.58 | 2 | $0 (2019) |
| Medtronic Vascular, Inc. | $13.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $238.09 | 7 | E.R. Squibb & Sons, L.L.C. ($166.78) |
| 2023 | $13.96 | 1 | E.R. Squibb & Sons, L.L.C. ($13.96) |
| 2022 | $14.29 | 1 | AstraZeneca Pharmaceuticals LP ($14.29) |
| 2020 | $134.32 | 1 | AngioDynamics, Inc. ($134.32) |
| 2019 | $53.58 | 2 | Janssen Pharmaceuticals, Inc ($53.58) |
| 2018 | $3,495 | 9 | AngioDynamics, Inc. ($3,365) |
| 2017 | $2,438 | 17 | AngioDynamics, Inc. ($1,175) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | ABECMA (Biological) | Food and Beverage | Cash or cash equivalent | $114.00 | General |
| Category: Oncology | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $11.16 | General |
| Category: Cardiovascular | ||||||
| 06/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $30.83 | General |
| Category: Cardiovascular | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $10.79 | General |
| Category: Cardiovascular | ||||||
| 06/27/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: Cardiovascular | ||||||
| 08/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2020 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $134.32 | General |
| Category: PAD | ||||||
| 07/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2018 | AngioDynamics, Inc. | EVLT (Device) | Education | In-kind items and services | $3,333.33 | General |
| Category: Peripheral Vascular | ||||||
| 11/16/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/02/2018 | Medtronic Vascular, Inc. | ClosureFast (Device) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: EndoVenous Therapies | ||||||
| 07/13/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/06/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2018 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $31.26 | General |
| Category: VIT | ||||||
| 02/23/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/09/2018 | ARALEZ PHARMACEUTICALS US INC. | ZONTIVITY (Drug), YOSPRALA | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/26/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2017 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $291.47 | General |
| Category: Peripheral Vascular | ||||||
| 12/12/2017 | Aralez Pharmaceuticals US Inc. | ZONTIVITY (Drug) | Food and Beverage | In-kind items and services | $124.93 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/28/2017 | AngioDynamics, Inc. | — | Travel and Lodging | In-kind items and services | $884.01 | General |
| Category: Peripheral Vascular | ||||||
| 09/15/2017 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 554 | 675 | $152,259 | $76,362 |
| 2022 | 8 | 469 | 578 | $141,450 | $70,456 |
| 2021 | 10 | 478 | 618 | $116,830 | $74,183 |
| 2020 | 8 | 358 | 482 | $66,279 | $48,380 |
Total Patients
1,859
Total Services
2,353
Medicare Billing
$269,381
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 146 | 147 | $50,862 | $26,908 | 52.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 127 | $28,067 | $13,580 | 48.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 14 | 14 | $21,182 | $11,342 | 53.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $22,040 | $10,750 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 115 | $18,084 | $9,147 | 50.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 14 | 14 | $7,530 | $2,488 | 33.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 134 | 165 | $4,290 | $2,042 | 47.6% |
| 93042 | Electrocardiogram (ecg) 1 to 3 leads with review by physician only | Office | 2023 | 17 | 17 | $204.00 | $103.87 | 50.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 114 | 115 | $47,283 | $21,963 | 46.4% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2022 | 14 | 15 | $22,135 | $13,113 | 59.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 119 | $24,019 | $12,502 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 59 | 95 | $15,558 | $8,006 | 51.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $14,990 | $6,899 | 46.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 19 | 19 | $7,232 | $3,668 | 50.7% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 13 | 13 | $4,543 | $2,402 | 52.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 121 | 157 | $5,690 | $1,904 | 33.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 115 | 118 | $37,275 | $23,108 | 62.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 186 | $30,300 | $20,760 | 68.5% |
| 93229 | Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2021 | 14 | 14 | $15,265 | $9,800 | 64.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 42 | 42 | $10,372 | $6,252 | 60.3% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 29 | 29 | $8,906 | $5,773 | 64.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 33 | $3,712 | $2,748 | 74.0% |
| 93978 | Ultrasound scan of vena cava or groin graft or vessel blood flow | Office | 2021 | 13 | 13 | $3,786 | $2,467 | 65.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 115 | 158 | $4,242 | $1,952 | 46.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $2,406 | $978.23 | 40.7% |
About Dr. Ephron Shohat, MD
Dr. Ephron Shohat, MD is a Cardiovascular Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437343282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ephron Shohat, MD has received a total of $6,387 in payments from pharmaceutical and medical device companies, with $238.09 received in 2024. These payments were reported across 38 transactions from 9 companies. The most common payment nature is "Education" ($3,333).
As a Medicare-enrolled provider, Shohat has provided services to 1,859 Medicare beneficiaries, totaling 2,353 services with total Medicare billing of $269,381. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Brooklyn, NY
- Active Since 09/04/2007
- Last Updated 09/19/2019
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1437343282
Products in Payments
- EVLT (Device) $3,333
- CVX-300CVX-300P (Device) $432.72
- TURBOELITE (Device) $198.63
- ZONTIVITY (Drug) $136.25
- ENTRESTO (Drug) $115.75
- ABECMA (Biological) $114.00
- FARXIGA (Drug) $78.79
- BRILINTA (Drug) $63.65
- TURBO POWER (Device) $63.00
- CAMZYOS (Drug) $55.95
- Repatha (Biological) $54.73
- XARELTO (Drug) $53.58
- ClosureFast (Device) $13.00
- ELIQUIS (Drug) $10.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Brooklyn
Dr. Felix Yang, M.d, M.D
Cardiovascular Disease — Payments: $599,451
Cardiovascular Disease $599,451
Ozgen Dogan, Md, MD
Cardiovascular Disease — Payments: $367,116
Cardiovascular Disease $367,116
Dr. Adam Budzikowski, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $346,063
Cardiovascular Disease $346,063
Dr. Peter Rouvelas, M.d, M.D
Cardiovascular Disease — Payments: $339,378
Cardiovascular Disease $339,378
Dr. Ronald Wharton, M.d, M.D
Cardiovascular Disease — Payments: $298,083
Cardiovascular Disease $298,083
Dr. Sorin Brener, Md, MD
Cardiovascular Disease — Payments: $225,799
Cardiovascular Disease $225,799